BIO applauds Representatives Leonard Lance (R-NJ) and Anna Eshoo (D-CA) for introducing the FDA Safety Over Sequestration Act, which would exempt privately paid user fees paid to FDA from any future operation of sequestration. BIO firmly believes that preventing FDA user fees from becoming subject to future periods of sequestration is critical to protecting patients and supporting public health, and calls on Congress to quickly consider and pass this vital legislation.